In-depth guide

UPDATED FEB 2026

Talcum Powder & Mesothelioma

Part of the Talcum Powder investigation

The short answer

Mesothelioma from asbestos-contaminated talcum powder represents a distinct and extremely serious category of claims in the talc litigation. Unlike the ovarian cancer claims, which involve the carcinogenic properties of talc itself, mesothelioma claims are based on asbestos contamination in J&J products — confirmed by J&J’s own internal documents and FDA testing.

The $117 million Lanzo verdict in New Jersey established that juries will hold J&J liable for mesothelioma from contaminated Baby Powder.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Asbestos in Baby Powder: The Mesothelioma Connection

Mesothelioma is a rare, aggressive, and almost always fatal cancer that develops in the mesothelial lining of the lungs (pleural mesothelioma), abdomen (peritoneal mesothelioma), or heart (pericardial mesothelioma). It is caused almost exclusively by exposure to asbestos fibers. In the talcum powder litigation, mesothelioma claims allege that asbestos contamination in J&J’s talc products delivered carcinogenic fibers to consumers who inhaled or ingested them during normal product use.

Talc and asbestos are minerals that naturally co-occur in geological deposits. The talc mining operations that supplied J&J’s Baby Powder frequently encountered asbestos fibers — including tremolite, anthophyllite, and chrysotile — which contaminated the talc supply. J&J’s internal documents from the 1970s show the company was aware of this contamination. In October 2019, the FDA confirmed the presence of chrysotile asbestos in commercially available J&J Baby Powder through independent testing.

Mesothelioma has a latency period of 20 to 50 years, meaning consumers exposed to asbestos-contaminated talc decades ago are being diagnosed today. The disease carries a devastating prognosis, with median survival of 12 to 21 months after diagnosis. Because of its severity and lethality, mesothelioma cases are typically valued higher than ovarian cancer cases in the talcum powder litigation.

The Lanzo Verdict and Mesothelioma Case Strength

The 2018 Lanzo v. J&J verdict in New Jersey — $117 million, including $80 million in punitive damages — established that juries will hold J&J liable for mesothelioma caused by asbestos-contaminated Baby Powder and Shower to Shower products. The Lanzo verdict was significant because it validated the asbestos contamination theory as a distinct legal pathway from the perineal talc-ovarian cancer claims.

Mesothelioma claims have inherent evidentiary strength because asbestos is a Group 1 carcinogen (definite human carcinogen) with no safe level of exposure, and mesothelioma is caused almost exclusively by asbestos. When a plaintiff can demonstrate they used J&J talc products and developed mesothelioma, the causal link is compelling. J&J’s own documents confirming asbestos contamination provide the critical evidence that the exposure occurred through their products.

Both consumer users and occupational workers may pursue mesothelioma claims. Consumers who regularly used Baby Powder or Shower to Shower and inhaled talc dust during application are at risk. Talc miners, mill workers, and cosmetic manufacturing workers who handled raw talc with asbestos contamination face elevated occupational exposure risk. Family members may file wrongful death claims for loved ones who died of mesothelioma from talc exposure.

Research & evidence

Scientific Evidence

meta-analysis

IARC Monograph Volume 136: Talc and Acrylonitrile

International Agency for Research on Cancer Working Group. (2024). IARC Monographs on the Identification of Carcinogenic Hazards to Humans

Key findings

  • Limited but consistent evidence in humans from epidemiological studies showing increased ovarian cancer risk with perineal talc use across multiple study designs and populations
  • Sufficient evidence of carcinogenicity in experimental animals, with talc causing tumors in multiple species and organ sites
  • Strong mechanistic evidence including chronic inflammation, oxidative stress, altered cell proliferation, and epigenetic alterations in exposed tissues
  • The upgrade to Group 2A reflects the accumulation of evidence since the 2006 Group 2B classification, including new large-scale epidemiological studies and improved mechanistic understanding
meta-analysis

Prospective Cohort Studies of Talc Use and Ovarian Cancer Risk

Harvard Nurses’ Health Study / Women’s Health Initiative Investigators. (2020). Journal of the National Cancer Institute / Journal of Clinical Oncology

Key findings

  • Consistent positive association between perineal talc use and ovarian cancer risk, with hazard ratios typically ranging from 1.20 to 1.40
  • Risk increased with duration of use, supporting a cumulative exposure model consistent with the chronic inflammation mechanism
  • The association was strongest for serous ovarian cancer, the most common and lethal histological subtype
  • Prospective study design provides stronger causal inference than case-control studies because talc use was reported before cancer diagnosis, eliminating recall bias
cross-sectional

Perineal Talc Use and Ovarian Cancer Risk: A Case-Control Study

Cramer DW, Welch WR, Scully RE, Wojciechowski CA. (1982). The Lancet

Key findings

  • Women who used talcum powder for perineal hygiene had an odds ratio of 1.92 for ovarian cancer compared to non-users
  • The risk increased with frequency and duration of use, suggesting a dose-response relationship
  • The study proposed the talc migration pathway: particles travel from the perineal area through the reproductive tract to the ovarian surface
  • Results were consistent across multiple cancer histological subtypes, supporting a general carcinogenic mechanism rather than subtype-specific effect

FAQ

Frequently Asked Questions

36 QUESTIONS

Yes. More than 63,000 lawsuits have been filed against Johnson & Johnson alleging that Baby Powder and other talc-based products caused ovarian cancer and mesothelioma. You may have a legal claim if you used J&J talcum powder products and were subsequently diagnosed with ovarian cancer, mesothelioma, fallopian tube cancer, peritoneal cancer, or endometrial cancer. The strongest claims involve long-term perineal use with a documented cancer diagnosis. Attorneys handle these cases on contingency. Fee arrangements vary, so confirm terms with any attorney you consult. The MDL 2738 in the District of New Jersey is actively coordinating thousands of federal cases, and state court proceedings continue nationwide.

Dive deeper

Related Guides

7 GUIDES

The full investigation

Part of the Talcum Powder Investigation